SEARCH RESULTS FOR: 失忆药买卖(加QQ:3551886549)口服迷情水srl-正宗深度昏睡的药gai04g(加QQ:3551886549)fcm(37945 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
MIC Tests Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Ceftazidime-avibactam 0.016/4 – 256 /4 µg/mL are specialized strips impregnated with a predefined concentration gradient of Ceftazidime and Avibactam for susceptibility testing of Citrobacter freundii, Enterobacter cloacae, Escherichia Coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis and Pseudomonas aeruginosa.
LIOFILCHEM SRL
Ceftazidime-Avibactam 0.016/4-256/4 10 Stripsµg/mL
In Commercial Distribution
- 18055182873354 ()
- 08055182873357 ()
- 08055182873333 ()
$92139-10
- Ceftazidime/avibactam minimum inhibitory concentration (MIC) IVD
MIC Tests Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Ceftazidime-avibactam 0.016/4 – 256 /4 µg/mL are specialized strips impregnated with a predefined concentration gradient of Ceftazidime and Avibactam for susceptibility testing of Citrobacter freundii, Enterobacter cloacae, Escherichia Coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis and Pseudomonas aeruginosa.
LIOFILCHEM SRL
Ceftazidime-Avibactam 0.016/4-256/4 µg/mL 1 Strip
In Commercial Distribution
- 28055182873344 ()
- 08055182873340 ()
- 18055182873347 ()
$92139-1
- Ceftazidime/avibactam minimum inhibitory concentration (MIC) IVD
MIC Test Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Linezolid 0.016 – 256 μg/mL are specialized strips impregnated with a predefined concentration gradient of Linezolid for susceptibility testing of Staphylococcus aureus (including methicillin-resistant isolates), Enterococcus faecium (vancomycin resistant isolates only).
LIOFILCHEM SRL
Linezolid 0.016 – 256 μg/mL 10 strips
In Commercial Distribution
- 18055182873323 ()
- 08055182873326 ()
- 08055182873302 ()
$92135-10
- Linezolid minimum inhibitory concentration (MIC) IVD
MIC Test Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Linezolid 0.016 – 256 μg/mL are specialized strips impregnated with a predefined concentration gradient of Linezolid for susceptibility testing of Staphylococcus aureus (including methicillin-resistant isolates), Enterococcus faecium (vancomycin resistant isolates only).
LIOFILCHEM SRL
Linezolid 0.016 – 256 μg/mL 1 strip
In Commercial Distribution
- 28055182873313 ()
- 08055182873319 ()
- 18055182873316 ()
$92135-1
- Linezolid minimum inhibitory concentration (MIC) IVD
The MTS™ Tetracycline 0.016-256 μg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to determine the minimum inhibitory concentration (MIC) in μg/mL of antimicrobial agents against bacteria as tested on agar media using overnight incubation and manual reading procedures. The MTS™ Tetracycline at concentrations of 0.016-256 μg/mL should be interpreted at 16-20 hours of incubation.
Tetracycline has been shown to be active both clinically and in vitro against these bacterial species according to the FDA drug approved label:
Staphylococcus aureus
Acinetobacter baumannii
Escherichia coli
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
LIOFILCHEM SRL
Tetracycline TE 0.016-256 µg/ml, 1 strip
In Commercial Distribution
- 18055182873057 ()
- 08055182873050 ()
- 08055182873036 ()
$92114-10
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
The MTS™ Tetracycline 0.016-256 μg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to determine the minimum inhibitory concentration (MIC) in μg/mL of antimicrobial agents against bacteria as tested on agar media using overnight incubation and manual reading procedures. The MTS™ Tetracycline at concentrations of 0.016-256 μg/mL should be interpreted at 16-20 hours of incubation.
Tetracycline has been shown to be active both clinically and in vitro against these bacterial species according to the FDA drug approved label:
Staphylococcus aureus
Acinetobacter baumannii
Escherichia coli
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
LIOFILCHEM SRL
Tetracycline TE 0.016-256 µg/ml, 1 strip
In Commercial Distribution
- 28055182873047 ()
- 08055182873043 ()
- 18055182873040 ()
$92114-1
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
No Description
LIOFILCHEM SRL
Piperacillin*- tazobactam TZP 0.016-256*
In Commercial Distribution
- 08055182872947 ()
- 08055182872961 ()
$92108-10
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
No Description
LIOFILCHEM SRL
Piperacillin*- tazobactam TZP 0.016-256*
In Commercial Distribution
- 18055182872951 ()
- 08055182872954 ()
- 28055182872958 ()
$92108-1
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
The Liofilchem® MTS™ (MIC Test Strip) Eravacycline 0.002-32 µg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of
bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to
determine the minimum inhibitory concentration (MIC) in µglmL of antimicrobial agents against bacteria as tested on agar media using ovemight
incubation and manual reading procedures. The MTS™ Eravacycline at concentrations of 0.002-32 µglmL should be interpreted at 16-20 hours of
incubation.
MTS™ Eravacycline can be used to dete1mine the MIC of eravacycline against the following bacteria.
Eravacycline has been shown to be active both clinically and in vitro against these bacterial species accoring to the FDA drug approved label:
Gram-positive bacteria
Enterococcus faecalis
Enterococcus faecium
Staphylococcus aureus
Gram-negative bacteria
Citrobacter freundii
Enterobacter cloacae
Escherichia coli
Klebsiella oxytoca
Klebsiella pneumoniae
Eravacycline has been shown to be active in vitro only against the non-fastidious bacteria listed below accoring to the FDA drug aprroved label:
Citrobacter koseri
Klebsiella (Enterobacter) aerogenes
LIOFILCHEM SRL
Eravacycline ERV 0.002-32 µg/mL 10 STRIP
In Commercial Distribution
- 18055182872906 ()
- 08055182872909 ()
- 08055182872886 ()
92104-10
- Eravacycline minimum inhibitory concentration (MIC) IVD
The Liofilchem® MTS™ (MIC Test Strip) Eravacycline 0.002-32 µg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of
bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to
determine the minimum inhibitory concentration (MIC) in µglmL of antimicrobial agents against bacteria as tested on agar media using ovemight
incubation and manual reading procedures. The MTS™ Eravacycline at concentrations of 0.002-32 µglmL should be interpreted at 16-20 hours of
incubation.
MTS™ Eravacycline can be used to dete1mine the MIC of eravacycline against the following bacteria.
Eravacycline has been shown to be active both clinically and in vitro against these bacterial species accoring to the FDA drug approved label:
Gram-positive bacteria
Enterococcus faecalis
Enterococcus faecium
Staphylococcus aureus
Gram-negative bacteria
Citrobacter freundii
Enterobacter cloacae
Escherichia coli
Klebsiella oxytoca
Klebsiella pneumoniae
Eravacycline has been shown to be active in vitro only against the non-fastidious bacteria listed below accoring to the FDA drug aprroved label:
Citrobacter koseri
Klebsiella (Enterobacter) aerogenes
LIOFILCHEM SRL
Eravacycline ERV 0.002-32 µg/mL 1 STRIP
In Commercial Distribution
- 08055182872893 ()
- 28055182872897 ()
- 18055182872890 ()
92104-1
- Eravacycline minimum inhibitory concentration (MIC) IVD
MTS is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Penicillin G 0.002-32 µg/mL are specialized strips impregnated with a predefined concentration gradient of Penicillin G for susceptibility testing of Streptococcus ssp.
LIOFILCHEM SRL
PENICILLIN G P 0.002-32 µg/mL 10 Strip
In Commercial Distribution
- 18055182872876 ()
- 08055182872879 ()
- 08055182872855 ()
$92103-10
- Penicillin G minimum inhibitory concentration (MIC) IVD
MTS is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Penicillin G 0.002-32 µg/mL are specialized strips impregnated with a predefined concentration gradient of Penicillin G for susceptibility testing of Streptococcus ssp.
LIOFILCHEM SRL
PENICILLIN G P 0.002-32 µg/mL 1 Strip
In Commercial Distribution
- 28055182872866 ()
- 08055182872862 ()
- 18055182872869 ()
$92103-1
- Penicillin G minimum inhibitory concentration (MIC) IVD
MTS™ (MIC Test Strip) Levofloxacin 0.002-32 μg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to determine the minimum inhibitory concentration (MIC) in μg/mL of antimicrobial agents against bacteria as tested on agar media using overnight incubation and manual reading procedures.
MTS™ Levofloxacin at concentrations of 0.002-32 μg/mL should be interpreted at 16-20 hours of incubation.
MTS™ Levofloxacin can be used to determine the MIC of levofloxacin against the following bacteria.
Levofloxacin has been shown to be active both clinically and in vitro against these bacterial species according to the FDA drug approved label:
Gram-negative bacteria
Enterobacter cloacae
Escherichia coli
Klebsiella pneumoniae
Proteus mirabilis
Pseudomonas aeruginosa
Serratia marcescens
Levofloxacin has been shown to be active in vitro only against the non-fastidious bacteria listed below according to the FDA drug approved label:
Citrobacter freundii
Citrobacter koseri
Klebsiella aerogenes
Klebsiella oxytoca
Morganella morganii
Proteus vulgaris
Providencia rettgeri
Providencia stuartii
LIOFILCHEM SRL
Levofloxacin LEV 0.002-32 μg/mL 10 Strip
In Commercial Distribution
- 18055182872579 ()
- 08055182872572 ()
- 08055182872558 ()
$92081-10
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
MTS™ (MIC Test Strip) Levofloxacin 0.002-32 μg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to determine the minimum inhibitory concentration (MIC) in μg/mL of antimicrobial agents against bacteria as tested on agar media using overnight incubation and manual reading procedures.
MTS™ Levofloxacin at concentrations of 0.002-32 μg/mL should be interpreted at 16-20 hours of incubation.
MTS™ Levofloxacin can be used to determine the MIC of levofloxacin against the following bacteria.
Levofloxacin has been shown to be active both clinically and in vitro against these bacterial species according to the FDA drug approved label:
Gram-negative bacteria
Enterobacter cloacae
Escherichia coli
Klebsiella pneumoniae
Proteus mirabilis
Pseudomonas aeruginosa
Serratia marcescens
Levofloxacin has been shown to be active in vitro only against the non-fastidious bacteria listed below according to the FDA drug approved label:
Citrobacter freundii
Citrobacter koseri
Klebsiella aerogenes
Klebsiella oxytoca
Morganella morganii
Proteus vulgaris
Providencia rettgeri
Providencia stuartii
LIOFILCHEM SRL
Levofloxacin LEV 0.002-32 μg/mL 1 Strip
In Commercial Distribution
- 28055182872569 ()
- 08055182872565 ()
- 18055182872562 ()
$92081-1
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
No Description
LIOFILCHEM SRL
Imipenem-relebactam I/R 0.002/4-32/4 10 Strip
In Commercial Distribution
- 18055182872487 ()
- 08055182872480 ()
- 08055182872466 ()
$92076-10
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
No Description
LIOFILCHEM SRL
Imipenem-relebactam I/R 0.002/4-32/4, 1 Strip
In Commercial Distribution
- 28055182872477 ()
- 08055182872473 ()
- 18055182872470 ()
$92076-01
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
No Description
LIOFILCHEM SRL
Omadacycline 0.002-32 µg/mL, 10 Strip
In Commercial Distribution
- 18055182872395 ()
- 08055182872398 ()
- 08055182872374 ()
$92071-10
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
No Description
LIOFILCHEM SRL
Omadacycline 0.002-32 µg/mL, 1 Strip
In Commercial Distribution
- 18055182872388 ()
- 08055182872381 ()
- 28055182872385 ()
$92071-1
- Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit
The Liofilchem® MTS™ (MIC Test Strip) is a quantitative method intended for the in vitro determination ofantimicrobial susceptibility of
bacteria MTS™ consists ofspecialized papyr impregnated with a pre-defined concentration gradient ofan antimicrobial agent, which is used to
determine the minimum inhibitozy concentration (MIC) in µglmL ofantimicrobial agents against bacteria as tested on agar media using ovemight
incubation and manual reading procedures. The MTS™ Plazomicin at concentrations of0.016-256 µglmL should be interpreted at 16-20 hours of
incubation.
MTS™ PLZ can be used to dete1mine the MIC ofplazomicin against the microorganisms listed below:
Plazomicin Activity According to the FDA Label
Clinical and in vitro
Enterobacter cloacae
Escherichia coli
Klebsiella pneumoniae
Proteus mirabilis
in vitro only
Citrobacterfreundii
Citrobacter koseri
Klebsiella (Enterobacter) aerogenes
Klebsiella oxytoca
Morganella morganii
Proteus vulgaris
Providencia stuartii
Serratia marcescens
LIOFILCHEM SRL
Plazomicin 0.016-256 µg/mL
In Commercial Distribution
- 08055182872367 ()
- 08055182872343 ()
- 18055182872364 ()
$92070-10
- Plazomicin minimum inhibitory concentration (MIC) IVD
The Liofilchem® MTS™ (MIC Test Strip) is a quantitative method intended for the in vitro determination ofantimicrobial susceptibility of
bacteria MTS™ consists ofspecialized papyr impregnated with a pre-defined concentration gradient ofan antimicrobial agent, which is used to
determine the minimum inhibitozy concentration (MIC) in µglmL ofantimicrobial agents against bacteria as tested on agar media using ovemight
incubation and manual reading procedures. The MTS™ Plazomicin at concentrations of0.016-256 µglmL should be interpreted at 16-20 hours of
incubation.
MTS™ PLZ can be used to dete1mine the MIC ofplazomicin against the microorganisms listed below:
Plazomicin Activity According to the FDA Label
Clinical and in vitro
Enterobacter cloacae
Escherichia coli
Klebsiella pneumoniae
Proteus mirabilis
in vitro only
Citrobacterfreundii
Citrobacter koseri
Klebsiella (Enterobacter) aerogenes
Klebsiella oxytoca
Morganella morganii
Proteus vulgaris
Providencia stuartii
Serratia marcescens
LIOFILCHEM SRL
Plazomicin 0.016-256 µg/mL
In Commercial Distribution
- 28055182872354 ()
- 08055182872350 ()
- 18055182872357 ()
$92070-1
- Plazomicin minimum inhibitory concentration (MIC) IVD